ÂÜÀòÂÒÂ×

Robert J. Bard is a consultant, acting Vice President of Quality and Regulatory Affairs at LumiThera. Prior to LumiThera, Mr. Bard has been the Managing Director at HealthCare Technologies Consultants LLC, the Vice President of Regulatory and Quality Systems at Sciele Pharma and the Vice President of Regulatory and Clinical Affairs and Quality Assurance at Aastrom Biosciences. Mr. Bard has 42 years of compliance, ethics, legal and regulatory affairs, quality control, quality assurance, clinical affairs and development, and manufacturing and operations experience in pharmaceuticals, devices, biotech and biologics industries. Therapeutic areas include ophthalmology, hematology, orthopedics, infusion therapy and pain management, neurology, oncology, dermatology, regenerative medicine and monoclonal antibiotic therapeutics. Mr. Bard earned a Bachelor of Science in Microbiology from the University of California (Los Angeles) and a Juris Doctorate from American College of Law. Mr. Bard is a member of the California Bar and is certified as a Regulatory Professional by the Regulatory Affairs Professional Society and a Certified Quality Engineer by the American Society for Quality.